On November 2, Huang Guo, director of the China Drug Administration, met with Heidi Silo, Acting Director of WHO's Regulatory and Pre-Certification Department, and Martin Taylor, the representative in China, and his entourage in Beijing. The two sides had in-depth discussions on cooperation matters such as evaluation of WHO listed institutions, capacity building for supervision, and personnel exchanges.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.